Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug KESONOTIDE™ enters human trials for multiple cancers

NCT ID NCT06926075

Recruiting now Disease control Sponsor: Filamon LTD Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new drug, KESONOTIDE™, in people with advanced solid tumors like prostate, breast, lung, ovarian, brain, pancreas, or skin cancer. The trial has two phases: first, finding the safest dose, then testing that dose in a larger group. About 80 participants will be enrolled to check safety and how the drug behaves in the body.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
KESONOTIDE™ (a vimentin inhibitor)
What this could lead to
If it works, this could point toward a new treatment option for several advanced solid cancers.
What could go wrong
This is an early phase trial with only 80 participants, so the drug may not prove effective or safe enough for wider use. Side effects are unknown at this stage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm glioblastoma glioma susceptibility 1 lung cancer lung neoplasm malignant pancreatic neoplasm ovarian cancer pancreatic neoplasm prostate cancer skin cancer skin neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER GLIOBLASTOMA MULTIFORME (GBM) LUNG CANCERS OVARIAN CANCER PANCREAS CANCER PROSTATE CANCERS SKIN CANCER

Contacts and locations

Locations

  • South Western Sydney Local Health District

    RECRUITING

    Liverpool, New South Wales, 2170, Australia

  • Southside Cancer Centre

    RECRUITING

    Miranda, New South Wales, 2228, Australia

    Contact Email: •••••@•••••

  • St George Private Hospital

    RECRUITING

    Kogarah, New South Wales, 2217, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.